GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eternity Healthcare Inc (GREY:ETAH) » Definitions » YoY EBITDA Growth

Eternity Healthcare (Eternity Healthcare) YoY EBITDA Growth : 0.00% (As of Jul. 2018)


View and export this data going back to 2008. Start your Free Trial

What is Eternity Healthcare YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Eternity Healthcare's YoY EBITDA Growth for the quarter that ended in Jul. 2018 was 0.00%.

Eternity Healthcare's EBITDA per Share for the three months ended in Jul. 2018 was $0.00.

Eternity Healthcare YoY EBITDA Growth Historical Data

The historical data trend for Eternity Healthcare's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eternity Healthcare YoY EBITDA Growth Chart

Eternity Healthcare Annual Data
Trend Apr09 Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.00 - 50.00 -100.00 50.00

Eternity Healthcare Quarterly Data
Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 100.00 -

Eternity Healthcare YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Eternity Healthcare's YoY EBITDA Growth for the fiscal year that ended in Apr. 2018 is calculated as:

YoY EBITDA Growth (A: Apr. 2018 )
=(EBITDA per Share (A: Apr. 2018 )-EBITDA per Share (A: Apr. 2017 ))/ | EBITDA per Share (A: Apr. 2017 ) |
=(-0.001--0.002)/ | -0.002 |
=50.00 %

Eternity Healthcare's YoY EBITDA Growth for the quarter that ended in Jul. 2018 is calculated as:

YoY EBITDA Growth (Q: Jul. 2018 )
=(EBITDA per Share (Q: Jul. 2018 )-EBITDA per Share (Q: Jul. 2017 )) / | EBITDA per Share (Q: Jul. 2017 )) |
=(-0--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eternity Healthcare YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Eternity Healthcare's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Eternity Healthcare (Eternity Healthcare) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eternity Healthcare Inc (GREY:ETAH) » Definitions » YoY EBITDA Growth
Comparable Companies
WAR:GEN WAR:NST WAR:BMX NIMU XSAT:ALPH INOL WAR:SCP XSAT:MEDF XMCE:EEP XKLS:0155 XSAT:IDL B BZYR MDIT OSTO:ADDV A WAR:IGN MHTX ASX:LSH ASX:PAA XCNQ:BUX TSX:GEN
Traded in Other Exchanges
N/A
Address
18 Carnarvon Road, Flat/Room 1006 - 10th Floor, Hang Seng Tsim Sha Tsui Building, Tsim Sha TsuiI, Kowloon, Hong Kong, HKG
Website
http://www.eternityhealthcare.com
Eternity Healthcare Inc is a medical device company operating in the us. It focuses on manufacturing a needle-free injection system. The company emphasizes needle-free injection device technology for application in Diabetes, Pediatric Oncology, Multiple sclerosis, Multiple sclerosis, Anesthetics, Vaccine, Cardiovascular, and Migraine. The company adult stem cell storage is all located in North China, East China, and South China. The company targets market includes Guizhou, Yunan, Guangxi, Xinjiang, and Tibet.